stempro34 media (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
stempro34 media
Stempro34 Media, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stempro34+media/stempro+34+sfm/pm40652798-41-15-23
Average 90 stars, based on 1 article reviews
Stempro34 Media, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stempro34+media/stempro+34+sfm/pm40652798-41-15-23
Average 90 stars, based on 1 article reviews
stempro34 media - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: DOT1L Methyltransferase Regulates Calcium Influx in Erythroid Progenitor Cells in Response to Erythropoietin Article Snippet: Single-cell suspensions of E10.5 wild-type and Dot1l KO yolk sacs were cultured in vitro in ESRE media (StemPro34 media containing nutrient supplement; ThermoFisher Scientific, Waltham, MA, USA), 2 U/mL human recombinant EPO (PeproTech, Inc., East Windsor, NJ, USA), 100 ng/mL SCF (PeproTech, Inc.), 10 μM dexamethasone (MilliporeSigma, Saint Louis, MO, USA), 40 ng/mL IGF1 (PeproTech, Inc., East Windsor, NJ, USA) and Article Title: Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm. Article Snippet: Sorted cells were cultured in StemPro34 (Thermo Fisher Scientific, Article Title: Sustained Levels of FGF2 Maintain Undifferentiated Stem Cell Cultures with Biweekly Feeding Article Snippet: Briefly, hESCs were plated at a density of 20,000 cells/cm 2 on matrigel (BD) coated dishes in MEF conditioned hESC medium (CM) with 10 ng/mL of FGF-2 and10uM ROCK-inhibitor (Tocris). Cell Culture:Article Title: Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Article Snippet: 6/ Substantial numbers of B cell leukemia and lymphoma patients relapse due to antigen loss or heterogeneity after anti-CD19 chimeric antigen receptor (CAR) T cell therapy.. To overcome antigen escape and address antigen heterogeneity, we engineered induced pluripotent stem cell-derived NK cells to express both an NK cell-optimized anti-CD19 CAR for direct targeting and a high affinity, non-cleavable CD16 to augment antibody-dependent cellular cytotoxicity.. In addition, we introduced a membrane-bound IL-15/IL-15R fusion protein to promote in vivo persistence. |